AT&T cut its dividend in 2022, and its stock performance has remained flat since. Verizon has increased its dividend for 19 consecutive years, but the stock has struggled in the past five years. Which ...

The grey G3 Gundam was an upgraded version of the regular Gundam featured in the novels written by Yoshiyuki Tomino. In a new update, the arcade heavyweight Gundam Extreme Versus 2 Infinite Boost gets ...

Granblue Fantasy Versus: Rising Character Pass Season 2 downloadable content character Meg will launch on October 15 for $7.99 alongside the game’s version 2.30 update, publisher Cygames and developer ...

Purpose: Although pulmonary arterial hypertension (PAH) associated with congenital heart disease (APAH-CHD) may show a progression to Eisenmenger Syndrome (ES), the clinical and hemodynamic aspects of ...

GitHub Copilot continues to evolve in both Visual Studio and Visual Studio Code, offering developers increasingly intelligent, context-aware tools that go far beyond basic autocomplete. The latest ...

Chad Thesen is a passionate fan of anime, video games, series, and films (Both animated and live-action). Many years of experience have left him with a deep knowledge of these mediums' intricacies and ...

Cygames has revealed the full roster of DLC characters who will appear as part of the Granblue Fantasy Versus Rising Season Pass 2. The new pass will contain a total of five characters, starting with ...

Apple and Google both have brand-new flagship phones. Which one is better? We compare specs to find out. I’m a mobile writer at PCMag, which means I cover wireless phones, plans, tablets, ereaders, ...

Multi-site randomized trial of a collaborative palliative and oncology care model for patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) receiving non-intensive therapy.

Without getting them into our lab, we don’t know if all those performance boasts actually hold water. Fortunately, Gordon got ahold of some hard data and covered it in the latest PCWorld YouTube video ...

A.I. companies are divided over whether the technology should be freely available to anyone for modifying and copying, or kept close for safekeeping. By Mike Isaac Mike Isaac has written about the ...

The MARIANE-trial: Multicenter phase 1b/2 trial testing safety and efficacy of neoadjuvant intradermal ipilimumab and nivolumab in high-risk stage II melanoma. This is an ASCO Meeting Abstract from ...